Please Wait a Moment
X

Articles

06Jul

FDA Releases Zika Virus (ZIKV) Guidance and Grifols ZIKV Assay Licensed

06 Jul, 2018 | Return|

On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to pooled ZIKV testing. Additionally, on July 5th Grifols received licensure for their NAT ZIKV test for both individual and pooled donations.

Check out the Communication page for the complete details on the NAT ZIKV test or by clicking the link: Communications

Related

CTS Charlotte Implements New Laboratory Information System

On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...

Read More >

2020 Annual CTS Survey

The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...

Read More >

Phoenix Laboratory Transition to the VISION Analyzer

On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...

Read More >

CTS conversion to the Ortho VERSEIA Integrated Processor (VIP) in January 2021

After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...

Read More >

Notification of Form Revisions to Implement on September 2, 2019

The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...

Read More >

Renewed licenses now available on the website

As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....

Read More >